Ferrara University Hospital
Ferrara, 44124, Italy
NCT Number: NCT02345525
The aim of this study is to evaluate the feasibility of a Home-based Constraint-Induced Movement Therapy (hCIMT) compared to a Modified Constraint-Induced Movement Therapy (mCIMT) delivered in a outpatient setting on upper limb motor recovery in stroke survivors.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Ferrara, 44124, Italy
Home-based Constraint Induced Modified Therapy (hCIMT) consist of 2 hours intensive upper limb practice with shaping techniques + 2 hours ADLs supervised by a caregiver. Patients are supposed to wear a mitt on the unaffected hand for 4 hours daily.
Modified Constraint Induced Modified Therapy (mCIMT) consist of 2 hours intensive upper limb practice with shaping techniques supervised by an experienced physiotherapist + 2 hours ADLs at home (supervised by a caregiver) Patients are supposed to wear a mitt on the unaffected hand for 4 hours daily.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This intervention is based on 3 main aspects:
The 2 hours massed practice will be performed in a outpatient clinic with a supervision of PT.
This intervention is based on 3 main aspects:
In this group, a comprehensive set of the material necessary to perform the training at home and a booklet containing an explanation of the exercises that can be done will be provided to subjects.
In addition, 2 hospital visits will be scheduled to instruct subjects and caregivers on the training and to update activities (1 visit at the beginning + 1 visit after 1 week).
Time frame: 1)A week prior to treatment beginning 2) the week after the end of treatment 4) at 3 months follow-up
Measure of upper extremity motor impairment. The upper extremity score ranges from 0-66.
Time frame: 1)A week prior to treatment beginning 2) the week after the end of treatment 4) at 3 months follow-up
Quantitative measure of upper extremity motor ability through timed and functional tasks.
Time frame: 1)A week prior to treatment beginning 2) the week after the end of treatment 4) at 3 months follow-up
Measures finger dexterity
Time frame: 1)A week prior to treatment beginning 2) the week after the end of treatment 4) at 3 months follow-up
Assessment of the change in real-world arm use in activities of daily living. Subjects are asked to score the quality of movement as well as amount of use of the affected arm in a number of common daily activities.
Time frame: 1)A week prior to treatment beginning 2) the week after the end of treatment 4) at 3 months follow-up
Self-assessment questionnaire assesses health status following stroke
Time frame: 1)A week prior to treatment beginning 2) the week after the end of treatment 4) at 3 months follow-up
Single-Pulse TMS will be used to study cortical-spinal tract excitability in primary motor cortex (M1).
Paired-pulse TMS Paired-Pulse TMS will be used to study intracortical excitability.
Time frame: 1)A week prior to treatment beginning 2) the week after the end of treatment 4) at 3 months follow-up
For the NIRS it will use an 32-channel NIRS imaging equipment which consist of 16 pairs of emitting and detecting optical fibers attached to a custom-made head cap placed on primary motor cortex.
NIRS measurements will be performed during 6 cycles of 15s hand reaching and grasping and 45s resting while sitting on a chair.
University Hospital of Ferrara
Other
The Feasibility of a Home-based Constraint-Induced Movement Therapy Program in Chronic Stroke Survivors.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02425345
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT05589402
Bone Diseases, Brain Diseases
Harlingen, Texas, United States
View Trial DetailsNCT06750692
Brain Diseases, Cardiovascular Diseases
Afyonkarahisar, Turkey (Türkiye)
View Trial DetailsNCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial Details